Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors.
dc.contributor.author | Fotouhi, O | |
dc.contributor.author | Kjellin, H | |
dc.contributor.author | Larsson, C | |
dc.contributor.author | Hashemi, J | |
dc.contributor.author | Barriuso, J | |
dc.contributor.author | Juhlin, C | |
dc.contributor.author | Lu, M | |
dc.contributor.author | Höög, A | |
dc.contributor.author | Pastrián, L | |
dc.contributor.author | Lamarca, Angela | |
dc.contributor.author | Soto, V | |
dc.contributor.author | Zedenius, J | |
dc.contributor.author | Mendiola, M | |
dc.contributor.author | Lehtiö, J | |
dc.contributor.author | Kjellman, M | |
dc.date.accessioned | 2016-10-12T13:01:06Z | |
dc.date.available | 2016-10-12T13:01:06Z | |
dc.date.issued | 2016-10 | |
dc.identifier.citation | Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors. 2016, 101 (10):3616-3627 J Clin Endocrinol Metab | en |
dc.identifier.issn | 1945-7197 | |
dc.identifier.pmid | 27459532 | |
dc.identifier.doi | 10.1210/jc.2016-2028 | |
dc.identifier.uri | http://hdl.handle.net/10541/619939 | |
dc.description.abstract | Somatostatin analogs are established in the treatment of neuroendocrine tumors (NETs) including small intestinal NET; however, the molecular mechanisms are not well known. Here, we examined the direct effects of lanreotide in NET cell line models. | |
dc.language | ENG | |
dc.language.iso | en | en |
dc.rights | Archived with thanks to The Journal of clinical endocrinology and metabolism | en |
dc.title | Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors. | en |
dc.type | Article | en |
dc.contributor.department | Department of Oncology-Pathology Karolinska Institutet, Stockholm | en |
dc.identifier.journal | The Journal of Clinical Endocrinology and Metabolism | en |
html.description.abstract | Somatostatin analogs are established in the treatment of neuroendocrine tumors (NETs) including small intestinal NET; however, the molecular mechanisms are not well known. Here, we examined the direct effects of lanreotide in NET cell line models. |